Vital Signs - Biomarkers in Clinical Trials - A Significant Competitive Advantage?
Vital Signs - Biomarkers in Clinical Trials - A Significant Competitive Advantage?
RELEASE DATE
09-Oct-2006
09-Oct-2006
REGION
North America
North America
Research Code: 9561-00-17-00-00
SKU: HC00455-NA-MR_03927
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00455-NA-MR_03927
Description
This issue of Vital Signs, released on October 9, 2006, provides a strategic overview and discussion of the use of biomarkers in clinical trials. Additionally, an emerging company profile is provided for Dendritic Nanotechnologies Inc., a company that specializes in the development and commercialization of dendrimers and dendritic polymers. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of September 25 - September 29, 2006.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on October 9, 2006, provides a strategic overview and discussion of the use of biomarkers in clinical trials. Additionally, an emerging company profile is provided for Dendritic Nanotechnologies Inc., a company that specializes in the development and commercialization of dendrimers and dendritic polymers. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of September 25 - September 29, 2006.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-17-00-00 |
Is Prebook | No |